3 results
Primary objectives of the study are to assess whether the administration of p53-SLP together with the local administration of IFNα is safe and able to induce a strong (directly ex-vivo detectable) p53-specific CD4+ T-cell response. Secondary…
The objective of this clinical study is to evaluate the safety and performance of the IASD System II in the treatment of heart failure patients with elevated left atrial pressure, who remain symptomatic despite appropriate medical management.
With a simple set of clinical tests we want to measure speech recognition performance in a group of normal hearing (NH) individuals and in a group of individuals with a specific hearing impairment. The purpose is to determine if and to what extent…